• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings

    4/15/24 10:00:00 AM ET
    $GS
    $LGVN
    $MRNS
    $ONVO
    Investment Bankers/Brokers/Service
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $GS alert in real time by email

    U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday.

    The Dow traded up 0.89% to 38,321.05 while the NASDAQ rose 0.70% to 16,288.03. The S&P 500 also rose, gaining, 0.80% to 5,164.30.

    Check This Out: Best Buy, Box And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

     

    Financial shares jumped by 1.5% on Friday.

    In trading on Friday, real estate shares rose by just 0.3%.

     

    Top Headline

     

    Goldman Sachs Group Inc. (NYSE:GS) reported better-than-expected first-quarter earnings on Monday.

    Goldman Sachs reported revenue of $14.21 billion for the first quarter of 2024, beating the consensus of $12.92 billion. The U.S. financial services giant reported EPS of $11.58, beating the consensus of $8.60.

     

    Equities Trading UP

     

    Soligenix, Inc. (NASDAQ:SNGX) shares shot up 98% to $0.7699 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA.

    Shares of Longeveron Inc. (NASDAQ:LGVN) got a boost, surging 70% to $2.87 following insider buys from multiple company executives.

    Organovo Holdings, Inc. (NASDAQ:ONVO) shares were also up, gaining 23% to $1.2613 after the company announced Phase 2 results for FXR314. Study results demonstrated statistically significant reduction in liver fat content from baseline in patients receiving FXR314 compared to placebo.

     

    Equities Trading DOWN

     

    Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) shares dropped 76% to $1.7680 after the company provided an update on the Phase 3 RAISE trial and reported preliminary Q1 financial results.

    Shares of ProMIS Neurosciences, Inc. (NASDAQ:PMN) were down 29% to $1.63.

    PaxMedica, Inc. (NASDAQ:PXMD) was down, falling 23% to $0.6501. PaxMedica, last week, announced the completed execution of three pivotal registration/validation batches of PAX-101.

    Also Check This Out: Wall Street's Most Accurate Analysts' Views On 3 Tech Stocks With Over 4% Dividend Yields

     

    Commodities

     

    In commodity news, oil traded up 0.5% to $85.43 while gold traded down 0.8% at $2,353.50.

    Silver traded down 0.6% to $28.075 on Friday, while copper rose 0.1% to $4.2580.

     

    Euro zone

     

    European shares were higher today. The eurozone’s STOXX 600 rose 0.8%, London’s FTSE 100 gained 0.1% while Spain’s IBEX 35 Index rose 0.6% The German DAX gained 1.4% French CAC 40 climbed 1.3% while Italy’s FTSE MIB Index jumped 1.5%.

    Industrial production in the eurozone increased by 0.8% month-over-month in February.

     

    Asia Pacific Markets

     

    Asian markets closed mostly lower on Monday, with Japan’s Nikkei 225 falling 0.74%, Hong Kong’s Hang Seng Index dropping 0.72%, China’s Shanghai Composite gaining 1.26% and India’s S&P BSE Sensex dipping 1.14%.

    Indian merchandise trade deficit shrank to $15.6 billion in March versus a year-ago gap of $18.1 billion, while wholesale prices rose by 0.53% year-over-year in March versus a 0.20% gain in the prior month.

     

    Economics

     

    The NY Empire State Manufacturing Index climbed to -14.3 in April versus prior month’s reading of -20.9.

    Retail sales increased 0.7% month-over-month in March following a revised 0.9% rise in February.

    Now Read This: Bitcoin Surpasses $66,000; Core Emerges As Top Gainer

    Get the next $GS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GS
    $LGVN
    $MRNS
    $ONVO

    CompanyDatePrice TargetRatingAnalyst
    Goldman Sachs Group Inc.
    $GS
    10/21/2025$750.00Overweight → Neutral
    Analyst
    Goldman Sachs Group Inc.
    $GS
    10/3/2025$785.00Market Perform
    BMO Capital Markets
    Goldman Sachs Group Inc.
    $GS
    7/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    Goldman Sachs Group Inc.
    $GS
    7/8/2025$627.00Hold → Reduce
    HSBC Securities
    Goldman Sachs Group Inc.
    $GS
    4/7/2025$558.00Overweight → Equal-Weight
    Morgan Stanley
    Goldman Sachs Group Inc.
    $GS
    4/4/2025$560.00Outperform → Neutral
    Daiwa Securities
    Goldman Sachs Group Inc.
    $GS
    3/19/2025Outperform → Perform
    Oppenheimer
    Goldman Sachs Group Inc.
    $GS
    2/27/2025$690.00 → $660.00Outperform → Mkt Perform
    Keefe Bruyette
    More analyst ratings

    $GS
    $LGVN
    $MRNS
    $ONVO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Abg Management Ltd. bought $8,499,988 worth of shares (700,741 units at $12.13) (SEC Form 4)

    4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)

    2/5/26 7:00:01 PM ET
    $PMN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Principal Accounting Officer Milbury Max A. bought $14,929 worth of shares (30,392 units at $0.49), increasing direct ownership by 203% to 45,389 units (SEC Form 4)

    4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)

    10/6/25 9:12:38 AM ET
    $PMN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CHAIRMAN, CEO AND PRESIDENT Schaber Christopher J bought $20,000 worth of shares (15,132 units at $1.32), increasing direct ownership by 3,993% to 15,511 units (SEC Form 4)

    4 - SOLIGENIX, INC. (0000812796) (Issuer)

    10/3/25 1:18:09 PM ET
    $SNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GS
    $LGVN
    $MRNS
    $ONVO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Coleman Denis P. sold $10,943,892 worth of shares (11,623 units at $941.57), decreasing direct ownership by 28% to 29,342 units (SEC Form 4)

    4 - GOLDMAN SACHS GROUP INC (0000886982) (Issuer)

    2/11/26 4:05:46 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    CHIEF RISK OFFICER Golten Alex S sold $2,143,045 worth of shares (2,292 units at $935.01), decreasing direct ownership by 20% to 4,809 units (SEC Form 4)

    4 - GOLDMAN SACHS GROUP INC (0000886982) (Issuer)

    2/11/26 4:03:17 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    Chief Scientific Officer Cashman Neil was granted 4,122 shares (SEC Form 4)

    4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)

    2/5/26 8:41:16 PM ET
    $PMN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GS
    $LGVN
    $MRNS
    $ONVO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman Sachs downgraded by Analyst with a new price target

    Analyst downgraded Goldman Sachs from Overweight to Neutral and set a new price target of $750.00

    10/21/25 7:15:32 AM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    BMO Capital Markets initiated coverage on Goldman Sachs with a new price target

    BMO Capital Markets initiated coverage of Goldman Sachs with a rating of Market Perform and set a new price target of $785.00

    10/3/25 8:40:01 AM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    Goldman Sachs downgraded by Citizens JMP

    Citizens JMP downgraded Goldman Sachs from Mkt Outperform to Mkt Perform

    7/14/25 8:39:57 AM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    $GS
    $LGVN
    $MRNS
    $ONVO
    SEC Filings

    View All

    SEC Form FWP filed by Goldman Sachs Group Inc.

    FWP - GOLDMAN SACHS GROUP INC (0000886982) (Subject)

    2/11/26 3:39:40 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    SEC Form FWP filed by Goldman Sachs Group Inc.

    FWP - GOLDMAN SACHS GROUP INC (0000886982) (Subject)

    2/11/26 1:55:33 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    SEC Form FWP filed by Goldman Sachs Group Inc.

    FWP - GOLDMAN SACHS GROUP INC (0000886982) (Subject)

    2/11/26 1:33:31 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    $GS
    $LGVN
    $MRNS
    $ONVO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NYSE Launches NYSE Texas Advisory Board to Shape Future Expansion in the State

    The New York Stock Exchange, part of Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced the launch of the NYSE Texas Advisory Board to support its mission to provide public companies with a listing and trading venue centered within the vibrant economy of the southwestern U.S. Founding members include Amanda Brock, Co-CEO of Solaris Energy Infrastructure (NYSE:SEI), Scott Mueller, Managing Director of the Southwestern region at Goldman Sachs (NYSE:GS), and Edward Crawford, Co-Founder and Co-CEO of Coltala Holdings. "Establishing the NYSE Texas Advisory Board on the one‑year anniversary of the announcement of NYSE Texas underscore

    2/12/26 8:00:00 AM ET
    $GS
    $ICE
    $SEI
    Investment Bankers/Brokers/Service
    Finance
    Oil and Gas Field Machinery
    Consumer Discretionary

    Soligenix Details Recent Progress and Upcoming Milestones

    PRINCETON, N.J., Feb. 12, 2026 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today issued an update letter from its President and Chief Executive Officer, Dr. Christopher J. Schaber.  The content of this letter is provided below. Dear Friends and Shareholders, I would like to start by thanking you for your continued support, and by wishing you and your families a Happy New Year. With 2026 being an imp

    2/12/26 7:30:00 AM ET
    $SNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bain Capital and Goldman Sachs Lead Financing for Truelink Capital's Acquisition of SouthernCarlson from Kyocera Corporation

    Bain Capital today announced that its Private Credit Group, alongside Private Credit at Goldman Sachs Alternatives, acted as co-Administrative Agents and Joint Lead Arrangers on a senior secured credit facility to support Truelink Capital's acquisition of SouthernCarlson from Kyocera Corporation, a global Japanese conglomerate. Terms of the financing were not disclosed. Founded in 1947 and headquartered in Omaha, Nebraska, SouthernCarlson is a leading U.S. distributor and service provider of construction and industrial fasteners, tools, and consumable supplies. The company operates a nationwide platform with more than 100 service branches and distribution locations, enabling rapid, high-f

    2/10/26 10:57:00 AM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    $GS
    $LGVN
    $MRNS
    $ONVO
    Financials

    Live finance-specific insights

    View All

    Presidio Announces Proposed $1 Billion Acquisition Financing Facility with Goldman Sachs

    Acquisition Facility expected to accelerate asset acquisition strategy Fort Worth, TX, Feb. 10, 2026 (GLOBE NEWSWIRE) --   Presidio Investment Holdings LLC ("Presidio" or the "Company"), a differentiated oil and gas operator focused on the acquisition and optimization of mature, producing oil and natural gas assets in the United States, and EQV Ventures Acquisition Corp. (NYSE:FTW) ("FTW"), a special purpose acquisition company sponsored by EQV Group, today announced that Presidio has mandated an affiliate of Goldman Sachs (NYSE:GS) to arrange up to $1.0 billion  in potential acquisition financing for Presidio following the completion of its business combination. Goldman Sachs Bank USA

    2/10/26 8:00:00 AM ET
    $EQV
    $FTW
    $GS
    Oil & Gas Production
    Energy
    Investment Bankers/Brokers/Service
    Finance

    Hut 8 Signs 15-Year, 245 MW AI Data Center Lease at River Bend Campus with Total Contract Value of $7.0 Billion

    15-year 245 MW IT lease valued at $7.0 billion over the base term and up to $17.7 billion if all renewal options are exercised Google providing a financial backstop covering obligations for the 15-year base lease term Hut 8 to implement an institutional-grade execution model designed to de-risk project delivery with blue-chip counterparties—Entergy (NYSE:ETR), J.P. Morgan (NYSE:JPM), Goldman Sachs (NYSE:GS), Vertiv (NYSE:VRT), and Jacobs (NYSE:J) MIAMI, Dec. 17, 2025 /PRNewswire/ -- Hut 8 Corp. (NASDAQ:HUT) (TSX:HUT) ("Hut 8" or the "Company"), an energy infrastructure platform integrating power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases

    12/17/25 6:15:00 AM ET
    $ETR
    $GS
    $HUT
    Electric Utilities: Central
    Utilities
    Investment Bankers/Brokers/Service
    Finance

    GridStor Announces Tolling Agreement and Start of Construction for Texas Battery Energy Storage Project

    150 MW Hidalgo County facility expected to begin operations by end of 2026 GridStor, a developer and operator of utility-scale battery energy storage systems, announced today execution of a tolling agreement with a Fortune 500 company for the Gunnar Reliability Project, a 150 MW, 300 MWh battery facility in Hidalgo County, Texas. The project has commenced construction and is expected to begin operations by the end of 2026. "At a time of rapidly increasing power demand, battery energy storage helps ensure affordable, reliable power to households and Lower Rio Grande Valley businesses," said Chris Taylor, CEO of GridStor. "We are proud to increase our commitment to building battery storage

    12/16/25 9:00:00 AM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    $GS
    $LGVN
    $MRNS
    $ONVO
    Leadership Updates

    Live Leadership Updates

    View All

    ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group

    Appointment reinforces ProMIS Neurosciences' strategic vision and deepens investor engagement as the Company advances its differentiated Alzheimer's program, PMN310 Cambridge, Massachusetts, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (NASDAQ:PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease (AD) and other neurodegenerative disorders, today announced that Slanix Paul Alex, Pharm.D., President and Portfolio Manager for Ally Bridge Group's Public Equity strategy, has joined the Company's Board of Directors. Dr. Alex has a highly distinguished Wall Street career spanning multiple leadership positions at public market

    10/22/25 7:30:00 AM ET
    $PMN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lambda Appoints Stacey Finerman as VP, Investor Relations

    Seasoned IR Leader from Zayo Group, Marqeta, and Square Brings Deep Expertise Lambda, the Superintelligence Cloud, today announced the appointment of Stacey Finerman as VP, Investor Relations. Finerman brings over a decade of experience in financial communications and capital markets strategy to support Lambda's next stage of growth as a leader in AI infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021703561/en/Stacey Finerman, VP, Investor Relations "We're delighted to have Stacey join our team. Stacey's significant experience strengthens our investor relations capabilities and adds a new set of relationships

    10/21/25 8:00:00 AM ET
    $C
    $EB
    $GS
    Major Banks
    Finance
    Computer Software: Programming Data Processing
    Technology

    Divcon Controls Names Marc Shiffman CEO

    With two decades of experience managing companies to exceptional results, Shiffman is well qualified to lead Divcon through a rapid phase of growth Divcon Controls ("Divcon"), a global systems integrator delivering facility management automation and monitoring solutions to the world's biggest mission-critical data center operators, announced today that Marc Shiffman has become its new Chief Executive Officer and has joined the company's Board of Directors. Mr. Shiffman joins Divcon with extensive experience in technology and services leadership, having successfully run multiple companies as an operationally adept executive in partnership with innovative founders. Most recently, Mr. Shif

    10/14/25 7:04:00 AM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    $GS
    $LGVN
    $MRNS
    $ONVO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Marinus Pharmaceuticals Inc.

    SC 13G/A - MARINUS PHARMACEUTICALS, INC. (0001267813) (Subject)

    11/15/24 10:35:20 AM ET
    $MRNS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by PaxMedica Inc.

    SC 13G/A - PaxMedica, Inc. (0001811623) (Subject)

    11/14/24 7:22:38 PM ET
    $PXMD
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Marinus Pharmaceuticals Inc.

    SC 13G - MARINUS PHARMACEUTICALS, INC. (0001267813) (Subject)

    11/14/24 6:39:04 PM ET
    $MRNS
    Biotechnology: Pharmaceutical Preparations
    Health Care